A novel site-specific proteomic screening test for ovarian cancer in a large prospective multi-institutional clinical study

Objective: Despite advancements in ovarian cancer (OC) therapy, the greatest benefit in survival would be the discovery of an effective screening test that could accurately detect early-stage disease. This study’s objective was to develop a site-specific proteomic-based triage test for OC using cervico-vaginal fluid (CVF).